Tag: fine needle aspiration

UPMC-KingMed Digital Pathology Venture Improves Patient Care

By Joseph Burns, from the Volume XXIII No. 4 – March 21, 2016 issue

CEO SUMMARY: Many experts think that digital pathology will make it possible to create international pathology subspecialty referral networks. Now in its fifth year, a partnership between UPMC’s Pathology Department and KingMed Diagnostics of China uses telepathology to give Chinese patients access to the subspecialist pathologists at UPMC. KingMed’s case referrals to UPMC rose from

View Article

Beckman Coulter, Olympus, LabCorp, Anthem, WellPoint, Medtox, University of Toronto

By Robert Michel, from the Volume XVII No. 3 - February 15, 2010 issue

BECKMAN COULTER REPORTS EARNINGS THAT INCLUDE OLYMPUS
THERE WAS A BIG JUMP in fourth quarter revenue at Beckman Coulter Inc., of Brea, California, which increased by 22% over the previous year, to $989.6 million.

This number included $120.2 million in revenue from the recent Olympus Diagnostics acquisition. Beckman Coulter spent $800 million in August 2009 to purchase

View Article

Global Laboratory Trends Dominated by Rising Costs and Labor Shortage

By Robert Michel, from the Volume XIV No. 9 - June 25, 2007 issue

“The Web has transformed many industries and it’s clearly affected our industry. This trend will help raise the bar in quality and overall performance among laboratories and manufacturers.”
—Jim Reid-Anderson
Chairman, President, and CEO of Dade Behring
CEO Summary: Recently, THE DARK REPORT conducted a roundtable interview with executives of Dade Behring. Present were Jim Reid-Anderson, Chairman, President

View Article

Mobile Pathology Service Fuels Increased Revenue

By Robert Michel, from the Volume XIV No. 4 - March 12, 2007 issue

CEO SUMMARY: When pathologist Raman Sukumar, M.D. founded a generalist pathology practice in 2003, he was convinced that local doctors would support his vision of pathology at the point of care. That vision was validated by rapid acceptance of his mobile pathology laboratory and a steady flow of new specimens. Doctors Pathology Services now employs

View Article

Pathologist Builds General Path Business From Office Lab

By Robert Michel, from the Volume XIII No. 16 - November 27, 2006 issue

CEO SUMMARY: Doctors Pathology Services in Delaware is successful for two reasons. First it runs the largest pathology lab in the state. But more important, it runs one of the few successful mobile pathology services anywhere. The Mobile Intraoperative Consultation Service(MICS)allows the pathologist to do pathology work on site at ambulatory surgery centers, physicians’ offices,

View Article

How Local Path Groups Can Keep Patient Access

By Robert Michel, from the Volume XI No. 13 - September 20, 2004 issue

CEO SUMMARY: For pathology groups operating their own histology and cytology labs, a growing problem is access to patients covered by exclusive managed care contracts. In the Northeast, several persistent pathology group practices are using some effective business strategies to fight this trend. Not every strategy works every time, but there are enough victories to

View Article

FNA Clinic Business Becomes Part of Unilab

By Robert Michel, from the Volume IX No. 2 - January 28, 2002 issue

CEO SUMMARY: Pathology has a new business model entering the marketplace. The goal of FNA Clinics of America, Inc. is to offer patients speedy access to the FNA procedure and provide referring physicians with a final diagnosis within hours of the FNA procedure. Unilab Corporation recognized the opportunity to support a value-added service and gain

View Article

Volume XXVI No. 2 – February 4, 2019

NOW THAT MOST HOSPITALS ARE INCLUDED as applicable laboratories that must report their PAMA private payer lab test price data to the Centers for Medicare and Medicaid Services, managers of those labs will benefit from the incisive analysis in this issue of the lessons learned during the 2017 PAMA reporting cycle. THE DARK REPORT further offers recommendations on how labs can do a better job of gathering and reporting their own data to CMS. Also, TDR delivers an exclusive analysis of why the Government Accounting Office's assertion that CMS will be paying billions more for Part B clinical lab tests is simply wrong.

See the full table of contents

Tag: fine needle aspiration

Enter Your Login Credentials